Spero Therapeutics at guggenheim conference: SP001 drives next phase
Spero Therapeutics at guggenheim conference: SP001 drives next phase
Similar Posts
Where Will Tesla Be in 5 Years?
In typical fashion, Tesla (TSLA -5.92%) has been an extremely volatile stock to own in the past five years. During this time, the share price fell at least 30% on three separate occasions. But unlike historical trends, this electric vehicle (EV) stock has underperformed the S&P 500 index over the trailing half decade. It’s up…
If Social Security’s funding crisis is the elephant in the room, this is the mouse everyone has overlooked. You have been warned.
“Delaying Social Security until 70 results in an increased monthly payment — and that comes with proportionally higher cost-of-living adjustments.”
Crafting the ideal loan package and what it can do for a broker’s business
Metrics such as return on investment (ROI) percentage or debt service coverage ratio (DSCR) are two straightforward ways a broker can forecast whether a given property will perform for life of the loan. Investors on a fix and flip project should be looking for a return in mid-20s to low-30s range to feel confident enough…
Cambridge BS widens two-year fixed mortgage range
The Cambridge Building Society has added to its two-year fixed mortgage range to accommodate first-time buyers, homemovers, remortgage customers and buy-to-let (BTL) borrowers. The mutual has launched a refreshed range featuring products at 80%, 90% and 95% loan to value (LTV), alongside a 70% LTV interest-only mortgage and its 98% LTV ‘First Step’ mortgage,…
We Went to NYC and My 2 Young Daughters Weren’t Into My Itinerary
New York City was home to my husband and me for six years before we had kids and moved to Asheville, and it will forever be a place that holds so much for us. That’s why when the timing, cost, and opportunity aligned for our family of four to vacation there for a week recently,…
